Danaher (NYSE:DHR) said it lured Brian Ellis from Medtronic (NYSE:MDT) to be its new general counsel, replacing Jonathan Graham, who jumpoed ship for Amgen (NSDQ:AMGN) last May.
Ellis was general counsel for Medtronic’s restorative therapies group, after stints as GC and chief compliance officer for monitoring solutions at GE Healthcare (NYSE:GE)
“Brian brings a wealth of experience leading and developing global legal teams and supporting business growth. I am confident that Brian’s background and experience position him to be a major contributor at Danaher,” president & CEO Thomas Joyce Jr. said in prepared remarks.
Akers Biosciences’ new CEO is BD vet Gormally
Akers Biosciences said it tapped Becton Dickinson & Co. (NYSE:BDX) veteran John Gormally to be its new CEO.
Read more
Uluru CEO Gray bows out
Uluru (OTC:ULUR) said president & CEO Kerry Gray resigned Nov. 20 and was replaced on an interim basis by board member Helmut Kerschbaumer.
Read more
Alphatec loses int’l SVP Bullivant
Alphatec (NSDQ:ATEC) said senior vice president of international Mark Bullivant resigned Nov. 13, with his duties to be assumed by other executives at the company.
Read more
Tandem Diabetes commercial chief Anacone steps down
Tandem Diabetes Care (NSDQ:TNDM) said its chief commercial officer, Robert Anacone, plans to retire effective Dec. 31.
Read more